Deputy Director of the Center, specializing in minimally invasive robotic surgery for urological tumors
Oncology
Research areas: Surgical treatment of urinary tract tumors, minimally invasive treatment with robot-assisted/laparoscopic surgery, comprehensive treatment of bladder cancer and testicular cancer, and pediatric oncological surgery. Cutting-edge technologies: Pioneered domestically in modified robot-assisted/laparoscopic retroperitoneal lymph node dissection for testicular cancer and ultra-extended lymph node dissection for bladder cancer. Director of the Expert Committee of the first international training
Affiliated Hospital
Sun Yat-sen University Cancer Center
→
Professor – Specializing in the internal medicine treatment of lymphoma and lung cancer
Oncology
Research areas: Medical treatment of tumors such as lymphoma, lung cancer, head and neck cancer, and gastrointestinal cancer; anti-tumor drugs and related clinical research. Cutting-edge technology: Dedicated to the medical treatment of tumors such as lymphoma, lung cancer, head and neck cancer, and gastrointestinal cancer. Conducted over 300 clinical studies on anti-tumor drugs and related research, and led the completion of registration clinical trials for more than 10 domestically produced new drugs an
Affiliated Hospital
Tianjin Medical University Cancer Hospital
→
Academician of the Chinese Academy of Engineering, Chief Physician, Tenured Professor, Doctoral Supervisor, Director of the National Clinical Research Center for New Drugs (Anti-tumor).
Oncology
Research areas: Personalized precision treatment for breast cancer and development of new anticancer drugs; clinical, applied basic and translational research on breast cancer. Cutting-edge technologies: Established a new method for personalized breast cancer screening, significantly improving early detection rates; pioneered a new field of personalized treatment based on molecular subtyping. Led the development of 19 guidelines, including the National Health Commission's "Guidelines for Rational Drug Use
Affiliated Hospital
Fudan University Cancer Hospital
→
Associate Chief Physician, Doctoral Supervisor
Oncology
-Research areas : Pediatric oncology, central nervous system tumors, proton therapy for soft tissue sarcoma. - Cutting-edge technologies: Optimization of proton dose for pediatric tumors to reduce long-term radiation damage during growth and development; stratified proton therapy for intracranial germ cell tumors and craniopharyngiomas. - Areas of expertise: intracranial tumors in children, rhabdomyosarcoma, solid tumors in adolescents, and soft tissue sarcoma in adults. - Academic Highlights: A pioneer i
Affiliated Hospital
Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
→
Professor, Chief Physician, Doctoral Supervisor, Leading Expert in Nasopharyngeal Carcinoma
Oncology
Research area : Precision radiotherapy and comprehensive treatment of nasopharyngeal carcinoma. Academic Highlights: A core expert in nasopharyngeal carcinoma at the Department of Radiation Oncology, China Cancer Hospital, who has driven multiple research findings to rewrite international clinical guidelines.
Affiliated Hospital
Sun Yat-sen University Cancer Center
→
Associate Chief Physician, Key Member of the Department of Medical Oncology
Oncology
Research areas : Comprehensive medical treatment of gastrointestinal tumors, hepatobiliary and pancreatic tumors, lung cancer, and breast cancer; Cutting-edge technologies: Targeted immunotherapy for solid tumors, management of adverse tumor reactions, and nutritional support; Areas of expertise: Gastric cancer, colorectal cancer, pancreatic cancer, and advanced solid tumors; Academic highlights: Visiting scholar at MD Anderson Cancer Center, and participation in multiple clinical trials of new anti-tumor
Affiliated Hospital
Tsinghua University Beijing Tsinghua Chang Gung Hospital
→
Professor – Center Director, specializing in gastrointestinal tumors and immunotherapy
Oncology
Research areas: Precision diagnosis and immunotherapy for digestive system tumors (colorectal cancer, gastric cancer, esophageal cancer), and clinical research on new cancer drugs. Cutting-edge technologies: The team's achievements in early diagnosis and precision treatment of digestive system tumors have reached international leadership, with multiple research findings adopted by global cancer diagnosis and treatment standards and guidelines. The team's research on dual immunotherapy will be published on
Affiliated Hospital
Sun Yat-sen University Cancer Center
→
Professor – Deputy Director of Internal Medicine, specializing in urological oncology and breast cancer
Oncology
Research areas: Precision diagnosis and treatment and clinical research of urological tumors and breast cancer. Cutting-edge technology: As the deputy director of internal medicine, he has extensive experience in the precision diagnosis and treatment and clinical research of urological tumors and breast cancer, and participates in the department's clinical research on new anti-tumor drugs and multidisciplinary diagnosis and treatment. Specializes in treating: urinary system tumors and breast cancer. Acade
Affiliated Hospital
Sun Yat-sen University Cancer Center
→
Chief Physician, Professor, Chief of Gastric Surgery
Oncology
Research areas : Gastric cancer, gastrointestinal stromal tumors; Cutting-edge technology: Neoadjuvant conversion therapy for advanced gastric cancer; Areas of expertise: locally advanced gastric cancer, recurrent gastric cancer, retroperitoneal tumors; Academic highlights: Standing Committee Member of the Gastric Cancer Committee of the Chinese Anti-Cancer Association; Core value: Constructing a translational surgery system for advanced gastric cancer to improve the chances of radical cure for unresectab
Affiliated Hospital
Sun Yat-sen University Cancer Center
→
Associate Chief Physician , Professor , Specializing in Day Chemotherapy and Comprehensive Management Model
Oncology
Research focus: Innovation in medical oncology treatment and comprehensive management models. Cutting-edge technology: Promoting the construction and optimization of the day chemotherapy clinic at the Xidan campus, establishing patient follow-up groups for long-term monitoring, and setting up joint medical and nursing clinics to provide patients with appointment services such as side effect management, follow-up examinations, and catheter maintenance, achieving comprehensive management. The day chemothera
Affiliated Hospital
Peking Union Medical College Hospital, Chinese Academy of Medical Sciences
→
Professor – Director of the Department of Lymphoma Medicine, specializing in the diagnosis and treatment of lymphoma and cellular immunotherapy.
Oncology
Research areas: Clinical diagnosis and treatment of lymphoma, autologous hematopoietic stem cell transplantation, CAR-T cell immunotherapy, and promotion of specialized diagnosis and treatment models for lymphoma. Cutting-edge Technology: The Department of Lymphoma, leading the way, is one of the earliest established clinical specialties for lymphoma in China. It pioneered the breaking down of traditional comprehensive treatment limitations, promoting a specialized lymphoma treatment model. It is now a na
Affiliated Hospital
Fudan University Cancer Hospital
→
Professor, Chief Physician, Doctoral Supervisor, Distinguished Professor of the Ministry of Education's "Changjiang Scholars Program"
Oncology
Research area : Precision radiotherapy and comprehensive treatment of nasopharyngeal carcinoma. Academic Highlights: Distinguished Professor of the "Changjiang Scholars Program" of the Ministry of Education; Youth Committee Member of the Chinese Medical Association's Radiation Oncology Therapy Committee; Published 35 SCI papers as first/corresponding author in the past 5 years, including Lancet Oncol and J Clin Oncol.
Affiliated Hospital
Sun Yat-sen University Cancer Center
→
Chief Physician, Professor , Vice President, Director of the Oncology Center, specializing in Precision, Intelligent, and Minimally Invasive Surgery for Gastrointestinal Tumors
Oncology
Research areas: Surgical treatment of gastrointestinal tumors, precision intelligent minimally invasive surgery for gastric cancer, and single-port laparoscopic resection of gastrointestinal tumors. Cutting-edge technology: Long-term commitment to systematic innovation in precision, intelligent, and minimally invasive gastric cancer surgery. Self-developed "disposable multi-channel single-port laparoscopic trocar," enabling free rotation of the dual endoscopes and lenses within a single channel, completel
Affiliated Hospital
Tsinghua University Beijing Tsinghua Chang Gung Hospital
→
Chief Physician, Professor, Doctoral Supervisor
Oncology
Research areas : radiotherapy and comprehensive treatment of nasopharyngeal carcinoma and head and neck tumors. Cutting-edge technology: A new technology for reducing the toxicity of "medial group retropharyngeal area radiotherapy exemption" for nasopharyngeal carcinoma (first of its kind, adopted by international guidelines). Academic Highlights: Published over 30 SCI papers as first/corresponding author (including BMJ and Nat Commun); Second Prize of National Science and Technology Progress Award (2023,
Affiliated Hospital
Sun Yat-sen University Cancer Center
→
Chief Physician, Doctoral Supervisor, Director of Radiation Oncology Department, Chief Expert of Proton Center
Oncology
-Research areas : Clinical translation of proton therapy, radiotherapy for breast cancer, cardiology oncology, and mechanisms of radiation-induced cardiac injury. - Cutting-edge technologies: Clinical trials and standardization of domestically produced proton systems; proton-induced cardiac protection strategies for mediastinal tumors. - Areas of expertise: Proton therapy for breast cancer, mediastinal lymphoma, thoracic and abdominal tumors, and skull base tumors. - Academic Highlights: Standing Committe
Affiliated Hospital
Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
→
Chief Physician, Professor, Master's Supervisor
Oncology
Research areas: Comprehensive treatment of lung cancer, esophageal cancer, and thymic tumors; three-dimensional conformal radiotherapy; diagnosis and treatment of radiation-induced lung injury; intraoperative radiotherapy for tumors. Cutting-edge technology: With 40 years of experience in radiotherapy, focusing on thoracic tumor radiotherapy since 1992, we have achieved top-tier domestic levels in the comprehensive treatment of lung cancer, esophageal cancer, thymic tumors, and prevention and treatment of
Affiliated Hospital
Wuwei Cancer Hospital, Gansu Province
→
Professor – Proton and Heavy Ion Radiation Physics
Oncology
Research areas: Radiation oncology physics, advances and clinical applications of proton and heavy ion radiotherapy technology. Cutting-edge technology: With many years of experience in research and clinical practice in radiation oncology physics, I possess profound expertise in the physical principles, dosimetry, and quality control systems of proton and heavy ion radiotherapy. I was invited to give a special report on "Advances and Prospects of Proton and Heavy Ion Radiotherapy Technology" at the academ
Affiliated Hospital
Wuwei Cancer Hospital, Gansu Province
→
Researcher and doctoral supervisor, specializing in medical physics and AI.
Oncology
Research areas : Multimodal big data fusion analysis of tumors; tumor diagnosis and postoperative prediction based on machine learning; medical imaging and multimodal big models. Cutting-edge technologies: AI-powered intelligent decision-making system for proton therapy; multimodal image fusion and radiotherapy planning optimization. Academic Highlights: Fellow of the American Association of Medical Physicists (FAAPM); presided over the key project of the Ministry of Science and Technology "Diagnostic and
Affiliated Hospital
Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
→
Professor , specializing in translational research on gastrointestinal tumors and cell therapy
Oncology
Research areas: Basic and clinical research on gastrointestinal tumors, focusing on neoadjuvant chemotherapy before surgery, adjuvant chemotherapy after surgery, and salvage chemotherapy and targeted therapy for patients with recurrent and metastatic gastrointestinal malignancies. Cutting-edge technologies: Led the translation of cutting-edge therapies such as CAR-T, TCR-T, and bispecific antibodies into clinical practice, promoting clinical research from "paper publication" to "truly solving clinical pro
Affiliated Hospital
Peking Union Medical College Hospital, Chinese Academy of Medical Sciences
→
Professor , specializing in precision diagnosis and comprehensive management of lung cancer
Oncology
Research focus: Precision diagnosis and treatment of lung cancer, with a focus on postoperative adjuvant therapy and advanced comprehensive treatment of EGFR mutation-positive non-small cell lung cancer. Cutting-edge technology: Led the world's first prospective clinical study on adjuvant therapy after surgery for stage IB and high-risk stage IA EGFR mutation-positive non-small cell lung cancer; participated in rewriting international guidelines for the treatment of unresectable stage III non-small cell l
Affiliated Hospital
Peking Union Medical College Hospital, Chinese Academy of Medical Sciences
→
Vice President of Fudan University Cancer Hospital, the leading expert in urology, the chief expert of the urological oncology MDT, the director of the Shanghai Institute of Urological Oncology, and the director of the Fudan University Prostate Cancer Institute
Oncology
He is also the Executive Director of the Chinese Anti-Cancer Association Integrated Prostate Oncology Committee, the Vice Chairman of the Chinese Anti-Cancer Association Integrated Urological Oncology Committee, the Chairman of the Chinese Anti-Cancer Association Male Reproductive System Tumor Committee (CACA-GO), the Chairman of the Prostate Cancer Expert Committee of the Chinese Society of Clinical Oncology (CSCO), the Chairman of the Urology Committee of the China Primary Health Care Foundation, the fo
Affiliated Hospital
Fudan University Cancer Hospital
→
Chief Physician, Dr., Doctoral Supervisor, Director of the Department of Colorectal Surgery at Fudan University Cancer Hospital, and Director of the Fudan University Colorectal Cancer Diagnosis and Treatment Center.
OncologyGastroenterology
Chief Expert of the Multidisciplinary Collaborative Group for Colorectal Cancer, Director of the Fudan University Colorectal Cancer Diagnosis and Treatment Center, Director of the Continuing Education Committee of the Chinese Clinical Oncology Collaboration Center, and Director of the Colorectal Cancer Professional Committee of the Shanghai Municipal Center for Disease Control and Prevention. He received a Mamadi Sodeva Memorial Funding Scholarship to visit the United States in 1987, obtained his Clinical
Affiliated Hospital
Fudan University Cancer Hospital
→
MD, Chief Physician, Dr., and Doctoral Supervisor in the Department of Pathology.
Oncology
Director of the Department of Pathology, Fudan University Cancer Hospital. Chairman of the Tumor Pathology Committee of the Shanghai Anti-Cancer Association, Director of the Shanghai Clinical Pathology Quality Control Center, and Standing Committee Member of the Tumor Pathology Professional Committee of the Chinese Anti-Cancer Association. He has long been engaged in the pathological diagnosis of various tumors, especially soft tissue tumors. He graduated from Nantong Medical College of the Ministry of Tr
Affiliated Hospital
Fudan University Cancer Hospital
→
Chief Physician, Dr., and Doctoral Supervisor. Currently serving as the Party Secretary of Fudan University Cancer Hospital and the Director of Shanghai Proton and Heavy Ion Center
Oncology
Dr. of Radiation Oncology, Shanghai Outstanding Academic Leader, Vice President of the Chinese Anti-Cancer Association, Chairman of the Radiation Oncology Committee of the Chinese Anti-Cancer Association, and Vice President of the Chinese Cancer Society. Graduated from Shanghai Medical University Research Institute in 1993. His main research areas are radiation therapy (including proton and heavy ion therapy) for breast and abdominal tumors, with particularly in-depth research in radiation therapy and mul
Affiliated Hospital
Fudan University Cancer Hospital
→
Doctor of Medicine, Chief Physician, Level 2 Dr., and Doctoral Supervisor. Currently serves as Director of the Thoracic Tumor Institute of Fudan University
ThoracicOncology
Chief Expert of the Multidisciplinary Diagnosis and Treatment Group for Thoracic Tumors, Director of the Lung Cancer Prevention and Treatment Center, and Director of the Department of Thoracic Surgery and ICU at Fudan University Cancer Hospital. Formerly served as President of Shanghai Chest Hospital. Received his Doctor of Thoracic and Cardiovascular Surgery degree from Shanghai Medical University in 1992. From 1997 to 1999, worked at St. Vicente Medical Center in Portland, USA, receiving comprehensive t
Affiliated Hospital
Fudan University Cancer Hospital
→
Chief Physician and Doctoral Supervisor of the Department of Pathology, Fudan University Cancer Hospital; Deputy Director (in charge of work) of the Department of Pathology.
Oncology
Graduated from the Department of Clinical Medicine, Shanghai Medical University in 1993, and received her Master's and Doctoral degrees in Oncology from the same university in 1996 and 1999, respectively. Studied at MD Anderson Cancer Center in the United States from 2000 to 2002. Serves as a member of the editorial board of the World Health Organization (WHO) Classification of Breast Tumors, a member of the expert group of the International Consortium for Reporting Cancer (ICCR), and the head of the Brea
Affiliated Hospital
Fudan University Cancer Hospital
→
Chief Physician, PhD, Doctoral Supervisor, Dr., Director of the Department of Pathology, and Head of the Thoracic Pathology Subspecialty.
Oncology
Deputy Director of the Thoracic Tumor Research Institute of Fudan University; Standing Committee Member and Chairman of the Youth Committee of the Tumor Pathology Committee of the Chinese Anti-Cancer Association, Deputy Leader of the Lung Cancer Group; Standing Committee Member of the Pathology Committee of the Chinese Research Hospital Association; Member of the Thoracic Pathology Group of the Pathology Committee of the Chinese Medical Association; Expert in Thoracic Pathology at the Shanghai Clinical Pa
Affiliated Hospital
Fudan University Cancer Hospital
→
Chief Physician, Dr., Deputy Director of the Department of Pathology, and Doctoral Supervisor. Head of the Molecular Pathology Laboratory, Department of Pathology, Fudan University Cancer Hospital.
Oncology
Received a Bachelor of Medicine degree from Nantong Medical College in 1988 and a Master of Pathology degree in 1991, and a Doctor of Oncology degree from Shanghai Medical University in 1998. Studied at MD Anderson Cancer Center in the United States from 2002 to 2004. Deputy Head of the PQCC Molecular Pathology Quality Control Group of the National Health and Family Planning Commission, Deputy Head of the Molecular Pathology Group of the Chinese Medical Doctor Association Pathologist Branch, Deputy Head o
Affiliated Hospital
Fudan University Cancer Hospital
→
Chief Physician, Dr., and Doctoral Supervisor. Vice Chairman of the Chinese Society of Pathology, Chairman of the Lymphoma Committee of the Chinese Anti-Cancer Association, Standing Committee Member of the Chinese Anti-Cancer Association
Oncology
Vice Chairman of the Shanghai Anti-Cancer Association, Director of the Shanghai Clinical Pathology Quality Control Center, Deputy Editor-in-Chief of the Chinese Journal of Pathology, Deputy Editor-in-Chief of the Chinese Journal of Cancer, Deputy Editor-in-Chief of the Journal of Clinical and Experimental Pathology, and Consultant to the Journal of Diagnostic Pathology. Lifetime Honorary Dr. of the Department of Pathology, Fudan University Cancer Hospital, and Honorary Chairman of the Lymphoma Committee o
Affiliated Hospital
Fudan University Cancer Hospital
→
Chief Physician, Dr., Doctoral Supervisor
Oncology
He received advanced training at MD Anderson Cancer Center in the United States in 1992 and 2000. He is the Director of the Clinical Cytology Committee of the Chinese Anti-Cancer Association, Vice Chairman of the Tumor Pathology Committee of the Chinese Anti-Cancer Association, Vice Chairman of the Chinese Association of Pathologists, Vice Chairman of the Pathology Committee of the Shanghai Medical Association, Vice Chairman of the Clinical Receptor Committee of the Shanghai Medical Association, Director
Affiliated Hospital
Fudan University Cancer Hospital
→
Dr.Chief Physician, and Doctoral Supervisor. Honorary Director of the Clinical Technology Committee of Shanghai Proton and Heavy Ion Hospital, Honorary Dr. of Fudan University Cancer Hospital
Oncology
Honorary Fellow of the American College of Radiology, and Vice President of the Chinese Anti-Cancer Association. Graduated from Shanghai First Medical College in 1970 and from the Graduate School of Shanghai Medical University in 1984. Worked at MD Anderson Cancer Center in the United States from 1986 to 1990 and from 1994 to 1996. Has been engaged in tumor radiotherapy for over 50 years, with nearly 20 years dedicated to research on proton and heavy ion tumor radiotherapy. Specializes in proton and heavy
Affiliated Hospital
Shanghai Proton and Heavy Ion Hospital
→
Doctor of Medicine, Chief Physician, Doctoral Supervisor, and Outstanding Academic/Technical Leader in Shanghai.
Oncology
Currently serving as Assistant to the President and Director of the Department of Head and Neck and Central Nervous System Oncology at Shanghai Proton and Heavy Ion Hospital. Principal Investigator of a Key Research and Development Program of the Ministry of Science and Technology, Chairman of the Proton and Heavy Ion Radiotherapy Committee of the China Association for the Promotion of Human Health Science and Technology, and Vice Chairman of the Particle Radiotherapy Committee of the Chinese Anti-Cancer
Affiliated Hospital
Shanghai Proton and Heavy Ion Hospital
→
Dr., Chief Physician, and Doctoral Supervisor. Director of the Radiation Therapy Center at Fudan University Cancer Hospital
Oncology
Director of the Department of Abdominal and Pelvic/Breast Tumors at Shanghai Proton and Heavy Ion Therapy Hospital. Standing Committee Member of the Radiation Therapy Committee of the Shanghai Anti-Cancer Association, Standing Committee Member of the Sarcoma Committee of the Shanghai Anti-Cancer Association, and Member of the Radiation Therapy Committee of the Shanghai Medical Association. Graduated from the Department of Medicine, Shanghai Medical University in 1988, and completed advanced training in th
Affiliated Hospital
Shanghai Proton and Heavy Ion Hospital
→
Chief Physician, Dr., and Doctoral Supervisor. Deputy Director of the Radiation Therapy Center, Fudan University Cancer Hospital; Director of the Radiation Therapy Department, Proton and Heavy Ion Center
Oncology
Member of the Chinese Society of Radiation Oncology, the Radiation Therapy Committee of the Chinese Anti-Cancer Association, the Clinical Oncology Collaboration Committee of the Chinese Anti-Cancer Association, and the Oncology Physicians Branch of the Chinese Medical Doctor Association; Director of the Shanghai Anti-Cancer Association and the Shanghai Nuclear Society; Chairman of the Radiation Therapy and Imaging Committee of the Shanghai Nuclear Society. Graduated from the Graduate School of Shanghai Me
Affiliated Hospital
Shanghai Proton and Heavy Ion Hospital
→
PhD in Oncology, Chief Physician, Doctoral Supervisor
Oncology
Currently serving as Assistant to the President and Director of the Department of Thoracic Oncology at Shanghai Proton and Heavy Ion Center, and Chief Physician of the Department of Radiation Oncology at Fudan University Cancer Hospital. Standing Committee Member of the Mediastinal Tumor Committee of the Chinese Anti-Cancer Association, Deputy Leader of the Preparatory Group of the Ion Radiotherapy Branch of the China Medical Equipment Association, Deputy Director of the Lung Cancer Targeted and Immunothe
Affiliated Hospital
Shanghai Proton and Heavy Ion Hospital
→
Chief Physician, Associate Chief Physician
Oncology
Currently serves as the Director of the Department of Abdominal and Pelvic Tumors at Shanghai Proton and Heavy Ion Center, a member of the Shanghai Medical Association's Committee on Radiation Oncology, a member of the Shanghai Anti-Cancer Association's Committee on Radiation Oncology, a standing member of the Shanghai Anti-Cancer Association's Committee on Sarcoma, and a member of the Shanghai Anti-Cancer Association's Committee on Multiple Primary and Unknown Primary Tumors. She has nearly 30 years of c
Affiliated Hospital
Shanghai Proton and Heavy Ion Hospital
→
Doctor of Medicine, Dr., Chief Physician, Doctoral Supervisor. Director of the Department of Gynecologic Oncology, Obstetrics and Gynecology Hospital Affiliated to Fudan University
OncologyObstetrics & Gynecology
Academic Leader in Shanghai Municipal Health System, Vice Chairman of the Ovarian Cancer Committee of the Chinese Anti-Cancer Association (Integrated Traditional Chinese and Western Medicine), Vice Chairman of the Tumor Genetics Branch of the Chinese Maternal and Child Health Association, Vice Chairman of the Gynecologic Oncology Committee of the Shanghai Anti-Cancer Association, and Deputy Editor-in-Chief of the *Chinese Journal of Metastatic Tumors*. Chief Expert of the Ovarian Cancer Team of the Fudan
Affiliated Hospital
Obstetrics and Gynecology Hospital Affiliated to Fudan University (Shanghai Red House Gynecology Hospital)
→
Chief Physician, MD, PhD, Doctoral Supervisor, Dr.. Vice President of the Department of Otolaryngology, Eye, Ear, Nose and Throat Hospital Affiliated to Fudan University, and Deputy Director of the Department of Otolaryngology
OncologyENT
Recipient of the Ministry of Education's New Century Excellent Talents Award, the National Science Fund for Distinguished Young Scholars, and the Shanghai Science and Technology Commission's Outstanding Academic Leader Award. Member of the Shanghai Branch of the Chinese Medical Association's Otolaryngology Branch, Head of the Head and Neck Surgery Group; Member of the Head and Neck Tumor Surgery Committee of the Chinese Anti-Cancer Association; Vice Chairman of the Head and Neck Tumor Committee of the Sha
Affiliated Hospital
Eye, Ear, Nose and Throat Hospital Affiliated to Fudan University (Shanghai ENT Hospital)
→
Doctor of Medicine, Chief Physician, Dr., and Doctoral Supervisor. Vice President of the Department of Otolaryngology, Deputy Director of the Department of Otolaryngology, and Director of the Department of Head and Neck Surgery at the Eye, Ear, Nose and Throat Hospital Affiliated to Fudan University
ENTOncology
Director of Teaching at the Standardized Training Base for Otolaryngology Residents and Specialists. Has served as Director of the Department of Head and Neck Surgery since July 2004. Studied postdoctorally at Paris VI University in France. Member of the French Society of Otorhinolaryngology-Head and Neck Surgery (La SFORL). Clinically, he mainly focuses on the diagnosis, open surgery, and robotic surgery of benign and malignant tumors of the oropharynx, laryngopharynx, salivary glands, and thyroid gland.
Affiliated Hospital
Eye, Ear, Nose and Throat Hospital Affiliated to Fudan University (Shanghai ENT Hospital)
→
Chief Physician, Dr., Doctoral Supervisor, MD. Director of the Department of Ophthalmology and Head of the Department of Ocular Oncology and Orbital Diseases at the Eye, Ear, Nose and Throat Hospital Affiliated to Fudan University
OncologyENT
Member of the Ocular Oncology and Oculoplastic Surgery Group of the Chinese Medical Association, Head of the Orbital Disease and Ocular Oncology Group of the Ophthalmology Branch of the Shanghai Medical Association, Executive Committee Member of the Asia-Pacific Society of Oculoplastic Surgery, Member of the American Academy of Oculoplastic Surgery, and Deputy Head of the Retinoblastoma Group of the Ophthalmology Branch of the Cross-Strait Medical and Health Exchange Association. Served as a member of the
Affiliated Hospital
Eye, Ear, Nose and Throat Hospital Affiliated to Fudan University (Shanghai ENT Hospital)
→
Chief Physician, Tenured Distinguished Dr., Doctoral Supervisor, Recipient of the National Science Fund for Distinguished Young Scholars
Oncology
Chief Scientist of the National Key Research and Development Program of China (973 Program), and Outstanding Academic Leader of Shanghai Municipality. Also serves as a Visiting Dr. at the Charlotte Hospital Group in Germany and a member of the European Association of Thoracic Surgeons. Performs over 2000 thoracic surgeries annually, specializing in single-port thoracoscopic surgery and early lung cancer screening, diagnosis, and prognostic assessment; in 2025, led the team to complete the department's 100
Affiliated Hospital
Shanghai Pulmonary Hospital (Shanghai Pulmonary Hospital Affiliated to Tongji University)
→
Professor , Executive Director of Phase I Clinical Trial Ward, specializing in brain metastases and ADC in triple-negative breast cancer.
Oncology
Research areas: Clinical and basic research on recurrent and metastatic breast cancer, clinical research on new anti-tumor drugs, and brain metastases of triple-negative breast cancer. Cutting-edge technology: Leading the development of the "ABC" three-drug combination regimen for treating TNBC brain metastases, achieving an intracranial objective response rate of 77.1% and a median overall survival of 21 months, with results published in JCO. At the 2028 ESMO BC conference, phase II data on Pumitamig com
Affiliated Hospital
Fudan University Cancer Hospital
→
